603939 益丰药房
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)11.13615.78313.83015.07012.694
总资产报酬率 ROA (%)4.6506.6455.4846.9456.381
投入资产回报率 ROIC (%)5.7268.0186.4695.5897.823

边际利润分析
销售毛利率 (%)39.54839.52940.34637.98139.008
营业利润率 (%)9.2459.4828.7368.6237.936
息税前利润/营业总收入 (%)9.6359.9689.4799.6538.299
净利润/营业总收入 (%)7.1017.1776.4646.3865.925

收益指标分析
经营活动净收益/利润总额(%)96.494100.03495.72296.01197.053
价值变动净收益/利润总额(%)2.4690.3662.5692.6101.373
营业外收支净额/利润总额(%)-0.069-0.429-0.072-0.543-0.144

偿债能力分析
流动比率 (X)1.0841.0951.1741.3061.339
速动比率 (X)0.7260.7210.7230.9360.850
资产负债率 (%)54.32456.64553.87963.04948.678
带息债务/全部投入资本 (%)34.86738.38833.575--39.146
股东权益/带息债务 (%)152.007129.728154.85991.106153.610
股东权益/负债合计 (%)78.79771.79581.42955.452100.941
利息保障倍数 (X)24.29618.91312.6478.96622.164

营运能力分析
应收账款周转天数 (天)29.42526.43822.3990.00023.733
存货周转天数 (天)99.57199.615102.6270.00093.656